| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |